Share
))
My Body Odyssey chronicles the rewards and challenges of individuals pursuing active lifestyles despite chronic illness, recurrent injury, behavioral issues and more. Their stories are complemented by insights from researchers, medical doctors, physical therapists, psychologists, and other wellness experts. An award-winning show, My Body Odyssey will be launching Season Two later this year. Subscribe and stay tuned to learn more! www.mybodyodyssey.com
…
continue reading
E173 - The PsychopharmaStahlogy Show: Alzheimer’s Disease and the Amyloid Controversy
Manage episode 352859655 series 1778252
Content provided by Neuroscience Education Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Neuroscience Education Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://cloudutil.player.fm/legal.
When it comes to Alzheimer’s disease, what is the amyloid cascade hypothesis? How has this theory impacted drug development for Alzheimer’s disease over the past three decades?
With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on Alzheimer’s disease, the amyloid hypothesis, disease modification, and breakthroughs in diagnosis and treatment.
Today, Dr. Andy Cutler interviews Dr. Stephen Stahl on the current state of Alzheimer’s disease and the amyloid controversy.
Let’s listen in to Part 1 of our theme: Alzheimer’s Disease and the Amyloid Controversy
Subscribe to the NEI Podcast, so that you don’t miss another episode!
195 episodes
